Practical points in the medical treatment of overactive bladder and  nocturia in the elderly

Publication date: March 2016 Source:Tzu Chi Medical Journal, Volume 28, Issue 1 Author(s): Jing-Liang Chen, Sheng-Fu Chen, Yuan-Hong Jiang, Hann-Chorng Kuo The prevalence of overactive bladder (OAB) increases with age. Degeneration of the central nervous system in the elderly has been proposed as one of the pathogenic factors of OAB. Antimuscarinic therapy is effective in the treatment of OAB; however, intolerable systemic adverse events and cognitive dysfunction during treatment with nonselective antimuscarinic agents is of growing concern in elderly patients. The newly developed beta-3 adrenoceptor agonist mirabegron does not adversely affect flow rate and detrusor pressure, and its therapeutic efficacy and tolerability are similar in patients aged > 65 years and > 75 years, suggesting it might be the therapeutic choice in older patients with OAB. Nocturia can cause sleep deprivation at night and increase daytime sleepiness and loss of energy in the elderly. Desmopressin add-on therapy is effective in improving nocturia and storage symptoms. However, elderly patients with a baseline serum sodium level below the normal range are at high risk of developing significant hyponatremia.
Source: Tzu Chi Medical Journal - Category: Universities & Medical Training Source Type: research